Division of Pediatric Surgery, Department of Surgery, Rush University Medical Center, 1653 West Congress Parkway, Kellogg 7, Chicago, IL 60612, United States.
Division of Pediatric Surgery, Department of Surgery, Rush University Medical Center, 1653 West Congress Parkway, Kellogg 7, Chicago, IL 60612, United States.
J Pediatr Surg. 2023 Mar;58(3):558-563. doi: 10.1016/j.jpedsurg.2022.03.032. Epub 2022 Apr 5.
BACKGROUND/PURPOSE: Despite evidence supporting short course outpatient antibiotic treatment following appendectomy for perforated appendicitis, evidence of real-world implementation and consensus for antibiotic choice is lacking. We therefore aimed to compare outpatient antibiotic treatment regimens in a national cohort.
We identified children who underwent surgery for perforated appendicitis between 2010 and 2018 using the PearlDiver database and compared 45-day disease-specific readmission between children who received shortened (5-8 days) versus prolonged (10-14 day) total antibiotic courses (inpatient intravenous and/or oral) completed with outpatient Amoxicillin/Clavulanate versus Ciprofloxacin/Metronidazole, and compared antibiotic type (5-14 days) to each other.
4916 children were identified, 2001 (90.0%) treated with Amoxicillin/Clavulanate (5-14 days), 381 (19.0%) with shortened (5-8 days), 1464 (73.2%) with prolonged (10-14 days) courses. 222 (10.0%) were treated with Ciprofloxacin/Metronidazole, 44 (19.8%) with shortened, 174 (78.4%) with prolonged courses. Freedom from readmission was not different between prolonged and shortened course whether they received Amoxicillin/Clavulanate (adjusted hazard ratio [AHR] 1.54, 95%CI 0.95-2.5) or Ciprofloxacin/Metronidazole (AHR 3.49, 95%CI 0.45-27.3). Antibiotic type did not affect readmission rate (Amoxicillin/Clavulanate versus Ciprofloxacin/Metronidazole, AHR 1.21, 95%CI 0.71-2.05).
Prolonged antibiotic regimens are routinely prescribed despite evidence suggesting shorter courses and antibiotic choice are not associated with greater treatment failure. As it is better tolerated, we recommend a shortened course of Amoxicillin/Clavulanate for oral management of perforated appendicitis.
Retrospective.
Level III.
背景/目的:尽管有证据支持穿孔性阑尾炎阑尾切除术后短期门诊抗生素治疗,但缺乏真实世界实施和抗生素选择共识的证据。因此,我们旨在比较全国队列中的门诊抗生素治疗方案。
我们使用 PearlDiver 数据库确定了 2010 年至 2018 年间接受手术治疗的穿孔性阑尾炎患儿,并比较了接受缩短(5-8 天)与延长(10-14 天)总抗生素疗程(住院静脉和/或口服)的患儿 45 天疾病特异性再入院率,这些患儿使用门诊阿莫西林/克拉维酸钾与环丙沙星/甲硝唑完成治疗,比较了抗生素类型(5-14 天)之间的差异。
共确定了 4916 名患儿,2001 名(90.0%)接受阿莫西林/克拉维酸钾(5-14 天)治疗,381 名(19.0%)接受缩短(5-8 天)治疗,1464 名(73.2%)接受延长(10-14 天)治疗。222 名(10.0%)接受环丙沙星/甲硝唑治疗,44 名(19.8%)接受缩短治疗,174 名(78.4%)接受延长治疗。无论接受阿莫西林/克拉维酸钾(调整后的危险比 [AHR] 1.54,95%CI 0.95-2.5)还是环丙沙星/甲硝唑(AHR 3.49,95%CI 0.45-27.3)治疗,延长疗程与缩短疗程的再入院率无差异。抗生素类型不影响再入院率(阿莫西林/克拉维酸钾与环丙沙星/甲硝唑,AHR 1.21,95%CI 0.71-2.05)。
尽管有证据表明较短疗程,但仍常规使用延长抗生素治疗方案,且抗生素选择与更高的治疗失败率无关。由于其耐受性更好,我们建议使用缩短疗程的阿莫西林/克拉维酸钾口服治疗穿孔性阑尾炎。
回顾性。
III 级。